Invention Application
- Patent Title: APOLIPOPROTEIN E FRAGMENTS
-
Application No.: US17617504Application Date: 2020-06-25
-
Publication No.: US20220251171A1Publication Date: 2022-08-11
- Inventor: Hiroaki Hagiwara , Kanta Horie , Kunihiko Kanatsu , Yasuharu Ishihara , Yasuaki Goto , Toru Oki , Masafumi Tsuboi , Charlotte Sahlin , Maria Eriksson , Christer Möller
- Applicant: EISAI R&D MANAGEMENT CO., LTD. , BioArctic AB
- Applicant Address: JP Tokyo; SE Stockholm
- Assignee: EISAI R&D MANAGEMENT CO., LTD.,BioArctic AB
- Current Assignee: EISAI R&D MANAGEMENT CO., LTD.,BioArctic AB
- Current Assignee Address: JP Tokyo; SE Stockholm
- Priority: EP19183411.18 20190628
- International Application: PCT/EP2020/067858 WO 20200625
- Main IPC: C07K14/775
- IPC: C07K14/775 ; G01N33/50 ; G01N33/92 ; A61P25/28
Abstract:
The present invention relates to novel fragments of apolipoprotein E (ApoE). These ApoE fragments have a variety of uses including as components of vaccine compositions, particularly vaccines for the prevention or treatment of neurological disorders such as Alzheimer's disease. The ApoE fragments may also be used in screening methods and methods of detection.
Information query
